October 21, 2019
ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) announced that Greg Drew, RPh, President of Value Drug Company, and Robert Mauch, PhD, PharmD, EVP and Group President of AmerisourceBergen Corporation, were recently elected to second terms as Chairman and Vice Chairman of the HDA Board of Directors.
Additionally, Saul Factor, RPh, President, Smith Drug Company, a Division of J M Smith Corporation, has joined the HDA Executive Committee, replacing Ted Scherr of Dakota Drug, who has stepped down after 10 years of leadership. Mr. Factor joins fellow Executive Committee members Victor Crawford, CEO Pharmaceutical Segment, Cardinal Health, Inc.; Paul Dickson, President, Morris & Dickson Co., L.L.C.; Chad Gielen, President/CEO, Louisiana Wholesale Drug Co. Inc.; and Kirk Kaminsky, President, Pharmaceutical Solutions & Services, McKesson Corporation, to execute HDA priorities, policies and positions as developed by its Board of Directors.
“I want to thank Ted for his dedicated service to the industry and welcome Saul to the Executive Committee,” said Drew. “I am pleased to once again serve the Alliance and the pharmaceutical distribution industry. Together with Bob and the rest of the HDA Board, I look forward to continuing our important work of promoting the value of distribution — and the safety, efficiency and reliability that distributors provide to the healthcare system.”
Additional information on the HDA Board of Directors, including a membership listing, is available at hda.org.
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s nonprofit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.